Notify me when INTERNATIONAL BIOTECHNOLOGY TRUST PLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | 65 | $296,845,651 | +$76,102,417 | -$91,456,405 | -$15,353,988 | AMGN, INCY, GILD, ITCI, BMRN | 13F-HR | 14 Nov 2023, 06:16 |
| Q2 2023 | 61 | $328,500,758 | +$109,067,793 | -$139,502,800 | -$30,435,007 | AMGN, INCY, HRMY, REGN, SUPN | 13F-HR | 08 Aug 2023, 06:30 |
| Q1 2023 | 64 | $358,401,018 | +$90,323,272 | -$59,652,454 | +$30,670,818 | SGEN, AMGN, INCY, HRMY, ALKS | 13F-HR | 18 May 2023, 07:12 |
| Q4 2022 | 63 | $323,783,350 | +$35,629,174 | -$60,614,565 | -$24,985,391 | HZNP, SGEN, INCY, ALKS, HRMY | 13F-HR | 01 Feb 2023, 06:16 |
| Q3 2022 | 66 | $311,859,000 | +$64,225,002 | -$57,189 | +$64,167,813 | HZNP, SGEN, INCY, ALKS, GILD | 13F-HR | 08 Nov 2022, 09:53 |
| Q2 2022 | 78 | $879,120 | $0 | $0 | $0 | SUPN, HZNP, ZLAB, GMAB, ALKS | 13F-HR | 16 Aug 2022, 09:56 |
| Q1 2022 | 70 | $20,347,000 | $0 | $0 | $0 | HZNP, KDNY, UTHR, BLACK DIAMOND THERAPEUTIC, APLS | 13F-HR | 20 May 2022, 09:37 |
| Q4 2021 | 73 | $438,872,000 | +$96,094,524 | -$55,077,314 | +$41,017,210 | AMGN, NBIX, ALNY, INCY, GILD | 13F-HR | 15 Feb 2022, 06:30 |
| Q3 2021 | 69 | $408,098,000 | +$122,471,283 | -$91,784,310 | +$30,686,973 | GILD, NBIX, HZNP, AMGN, BHVN | 13F-HR | 12 Nov 2021, 09:47 |
| Q2 2021 | 67 | $375,216,000 | +$89,161,392 | -$90,412,849 | -$1,251,457 | GILD, ALNY, SGEN, HZNP, REGN | 13F-HR | 11 Aug 2021, 06:54 |
| Q1 2021 | 56 | $378,079,000 | +$120,184,316 | -$77,882,079 | +$42,302,237 | HZNP, GILD, REGN, NBIX, EXEL | 13F-HR | 17 May 2021, 09:46 |
| Q4 2020 | 52 | $366,148,000 | +$86,034,869 | -$56,206,314 | +$29,828,555 | HZNP, ACAD, VRTX, BMRN, PTCT | 13F-HR | 19 Feb 2021, 10:31 |
| Q3 2020 | 53 | $309,768,000 | +$54,316,225 | -$67,324,749 | -$13,008,524 | HZNP, NBIX, GILD, ACAD, BMRN | 13F-HR | 01 Dec 2020, 08:37 |
| Q2 2020 | 53 | $300,837,000 | +$53,106,426 | -$27,593,542 | +$25,512,884 | HZNP, BMRN, GILD, VRTX, IMMU | 13F-HR | 14 Jul 2020, 15:47 |
| Q1 2020 | 56 | $219,373,000 | +$39,274,906 | -$68,520,393 | -$29,245,487 | VRTX, GILD, BIIB, BMRN, ACAD | 13F-HR | 18 May 2020, 06:07 |
| Q4 2019 | 63 | $277,590,000 | +$69,156,139 | -$49,118,795 | +$20,037,344 | VRTX, GILD, AMGN, ACAD, NBIX | 13F-HR | 18 May 2020, 06:05 |
| Q3 2019 | 58 | $216,398,000 | +$21,129,107 | -$39,438,004 | -$18,308,897 | GILD, CELG, VRTX, NBIX, AMGN | 13F-HR | 14 Nov 2019, 06:10 |
| Q2 2019 | 64 | $269,707,000 | +$70,843,142 | -$64,447,908 | +$6,395,234 | GILD, VRTX, NBIX, CELG, ALXN | 13F-HR | 14 Aug 2019, 06:30 |
| Q1 2019 | 62 | $270,681,000 | +$50,473,000 | $0 | +$50,473,000 | CELG, GILD, REGN, STML, ALXN | 13F-HR | 14 May 2019, 11:22 |
| Q4 2018 | 45 | $0 | $0 | $0 | $0 | 13F-HR | 14 Feb 2019, 10:00 | |
| Q3 2018 | 51 | $2,000 | $0 | $0 | $0 | RSLS | Restatement | 14 Nov 2018, 15:15 |
| Q2 2018 | 54 | $260,427,000 | +$46,585,542 | -$56,274,695 | -$9,689,153 | NBIX, CELG, VRTX, ILMN, ARRY | 13F-HR | 13 Aug 2018, 06:07 |
| Q1 2018 | 63 | $256,338,000 | +$60,384,546 | -$68,913,303 | -$8,528,757 | CELG, SHPG, ARRY, NBIX, BIIB | 13F-HR | 15 May 2018, 08:00 |
| Q4 2017 | 65 | $283,639,000 | +$68,227,366 | -$33,987,486 | +$34,239,880 | BIIB, CELG, REGN, NKTR, EXEL | 13F-HR | 02 Mar 2018, 16:05 |
| Q3 2017 | 56 | $256,889,000 | +$57,314,942 | -$78,323,847 | -$21,008,905 | CELG, BIIB, REGN, VRTX, ALXN | 13F-HR | 02 Mar 2018, 16:11 |
| Q2 2017 | 60 | $263,163,000 | +$55,044,902 | -$64,641,742 | -$9,596,840 | REGN, CELG, VRTX, BIIB, ALXN | 13F-HR | 02 Mar 2018, 16:06 |
| Q1 2017 | 60 | $261,246,000 | +$73,142,722 | -$52,001,939 | +$21,140,783 | CELG, BIIB, REGN, INCY, ALXN | 13F-HR | 02 Mar 2018, 16:05 |
| Q4 2016 | 49 | $221,987,000 | $0 | $0 | $0 | CELG, BIIB, ALXN, SHPG, TSRO | 13F-HR | 02 Mar 2018, 16:06 |